Trends in Medicare utilization and reimbursement for hematology/oncology procedures from 2012 to 2023: A geriatric oncology perspective

IF 2.2 Q3 GERIATRICS & GERONTOLOGY

Aging Medicine Pub Date : 2024-04-09 DOI:10.1002/agm2.12298

J. Conic, T. Reske

{"title":"Trends in Medicare utilization and reimbursement for hematology/oncology procedures from 2012 to 2023: A geriatric oncology perspective","authors":"J. Conic, T. Reske","doi":"10.1002/agm2.12298","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Objectives</h3>\n \n <p>Given the scarcity of data exploring reimbursement trends in the field of hematology/oncology, we sought to characterize these trends for common procedures in this field from 2012 to 2023.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>Using the Centers for Medicare and Medicaid Services' Physician Fee Schedule Look-Up Tool we collected reimbursement data for 40 hematology/oncology procedure codes from 2012 to 2023. Data was adjusted to 2023 United States (US) dollars using the Consumer Price Index (CPI).</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>From 2012 to 2023 gross reimbursement for the facility price decreased 4.4% and increased 9.2% for the non-facility price. When adjusted for inflation, compensation decreased 96.1% and 96.6%, respectively. None of the 40 examined Current Procedural Terminology (CPT) codes increased in net reimbursement over the study period.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>Medicare reimbursement for common hematology/oncology procedures decreased from 2012 to 2023. Further research is necessary to explore the implications of these trends on the delivery of patient care.</p>\n </section>\n </div>","PeriodicalId":32862,"journal":{"name":"Aging Medicine","volume":"7 2","pages":"171-178"},"PeriodicalIF":2.2000,"publicationDate":"2024-04-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/agm2.12298","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Aging Medicine","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/agm2.12298","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"GERIATRICS & GERONTOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Objectives

Given the scarcity of data exploring reimbursement trends in the field of hematology/oncology, we sought to characterize these trends for common procedures in this field from 2012 to 2023.

Methods

Using the Centers for Medicare and Medicaid Services' Physician Fee Schedule Look-Up Tool we collected reimbursement data for 40 hematology/oncology procedure codes from 2012 to 2023. Data was adjusted to 2023 United States (US) dollars using the Consumer Price Index (CPI).

Results

From 2012 to 2023 gross reimbursement for the facility price decreased 4.4% and increased 9.2% for the non-facility price. When adjusted for inflation, compensation decreased 96.1% and 96.6%, respectively. None of the 40 examined Current Procedural Terminology (CPT) codes increased in net reimbursement over the study period.

Conclusions

Medicare reimbursement for common hematology/oncology procedures decreased from 2012 to 2023. Further research is necessary to explore the implications of these trends on the delivery of patient care.

Abstract Image

查看原文本刊更多论文

2012 年至 2023 年医疗保险对血液学/肿瘤学程序的使用和报销趋势：老年肿瘤学视角

鉴于探讨血液学/肿瘤学领域报销趋势的数据很少，我们试图描述 2012 年至 2023 年该领域常见手术的趋势。我们使用医疗保险和医疗补助服务中心的医生收费表查询工具，收集了 2012 年至 2023 年 40 个血液学/肿瘤学手术代码的报销数据。从 2012 年到 2023 年，设备价格的报销总额下降了 4.4%，非设备价格的报销总额增长了 9.2%。经通货膨胀调整后，补偿额分别下降了 96.1%和 96.6%。在研究期间，40 个受检的现行医疗程序术语（CPT）代码中没有一个的净补偿额有所增加。有必要开展进一步研究，探讨这些趋势对患者护理服务的影响。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Aging Medicine Medicine-Geriatrics and Gerontology

CiteScore

4.10

自引率

0.00%

发文量